4-Methylmorpholine → HCID 21089030, compound

HRID 350908Notes

Reaction equation

HRID 350908 reaction equation
[Br:1][C:2]1[C:7](=[O:8])[N:6]([C:9]2[CH:10]=[C:11]([CH:15]=[CH:16][C:17]=2[CH3:18])[C:12](O)=[O:13])[C:5]([CH3:19])=[N:4][C:3]=1[O:20][CH2:21][C:22]1[CH:27]=[CH:26][C:25]([F:28])=[CH:24][C:23]=1[F:29].CN1CCOCC1.C(OC(Cl)=O)C(C)C.[CH3:45][C@@H:46]([NH2:49])[CH2:47][OH:48]>CC(N(C)C)=O.ClCCl>[Br:1][C:2]1[C:7](=[O:8])[N:6]([C:9]2[CH:10]=[C:11]([CH:15]=[CH:16][C:17]=2[CH3:18])[C:12]([NH:49][C@H:46]([CH3:45])[CH2:47][OH:48])=[O:13])[C:5]([CH3:19])=[N:4][C:3]=1[O:20][CH2:21][C:22]1[CH:27]=[CH:26][C:25]([F:28])=[CH:24][C:23]=1[F:29]

Participants

7

Reactant 4

HCID 79724-MethylmorpholineHCID 62365Isobutyl chloroformateHCID 80308(R)-(-)-2-Amino-1-propanolHCID 210892453-[5-Bromo-4-[(2,4-difluorobenzyl)oxy]-2-methyl-6-oxopyrimidin-1(6H)-yl]-4-methylbenzoic acid

Product 1

HCID 21089030HCID 21089030, compoundYield 49%

Reagents, catalysts & solvents 2

HCID 6344DichloromethaneSolvent2×HCID 31374DimethylacetamideSolvent

Conditions

Temperature
0 °C

Procedure

To a solution of 3-[5-bromo-4-[(2,4-difluorobenzyl)oxy]-2-methyl-6-oxopyrimidin-1(6H)-yl]-4-methylbenzoic acid (4.0 g, 0.0086 mol) in dimethylacetamide (10.0 mL) at −20° C. was added N-methylmorpholine (1.2 g, 0.012 mol), followed by the dropwise addition of a solution of isobutylchloroformate (1.58 g, 0.012 mmol) in dichloromethane (5.0 mL). The reaction mixture was stirred for 10 min. under argon atmosphere after which it was stirred at room temperature for 20 min. The reaction mixture was then cooled to 0° C., and added R-2-amino-1-propanol (0.97 g, 1.01 mol). The resulting mixture was stirred at room temperature for 1.5 h, concentrated in vacuo, and the residue was purified by reverse-phase HPLC using 10–90% CH3CN/Water gradient (40 min) at a flow rate of 80 mL/min. The appropriate fractions (MH+, m/z=522) were combined, and freeze-dried to give a white solid. This was dissolved in dichloromethane (20 mL), washed successively with 5% sodium bicarbonate (2×15 mL), water (2×20 mL), dried (Na2SO4), and concentrated to dryness to afford the racemic title compound (2.2 g, 49%) as a white amorphous substance: 1H NMR (CD3OD/400 MHz) δ 7.91(dd, 1H, J=1.6 Hz, & 6.4 Hz), 7.68 (d, 1H, J=1.6 Hz), 7.60 (m, 1H), 7.53 (d, 1H, J=8.4 Hz), 7.01 (m, 2H), 5.57 (abq, 2H), 4.18 (m, 1H), 3.56 (m, 2H), 2.17 (s, 3H), 2.13 (s, 3H), and 1.22(d, 3H, J=6.8 Hz); ES-HRMS m/z 522.0860 (M+H calcd for C23H23N3O4F2Br requires 522.0835). 19F NMR(CD3OD/400 MHz) −111.85(m) and −115.90 (m).

Workup

  1. stirringwas stirred at room temperature for 20 min
  2. stirringThe resulting mixture was stirred at room temperature for 1.5 h
  3. concentrationconcentrated in vacuo
  4. customthe residue was purified by reverse-phase
  5. custom10–90% CH3CN/Water gradient (40 min)
  6. customfreeze-dried
  7. customto give a white solid
  8. washwashed successively with 5% sodium bicarbonate (2×15 mL), water (2×20 mL)
  9. dry with materialdried (Na2SO4)
  10. concentrationconcentrated to dryness

Sources & evidence

ORD record
ord-db0dd2d5e02c45f5bf9d4ac03c03cd42
Source dataset
uspto-grants-2007_02
Patent number
US07183287B2

Reaction notes

Loading…